nach oben

Journal of Behavioral Medicine

Erschienen in:

31.03.2021

Forgoing antiretroviral therapy to evade stigma among people living with HIV, Cape Town, South Africa

verfasst von: Seth Kalichman, Catherine Mathews, Renee El-Krab, Ellen Banas, Moira Kalichman

Erschienen in: Journal of Behavioral Medicine | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Stigma impedes HIV treatment in multiple ways, including diminished engagement in care, refusing ART, and concealing ART to evade stigma. This study disentangled the degree to which intentionally not taking ART to evade stigma influences overall non-adherence to ART. Patients receiving ART at a community clinic in Cape Town, South Africa (N = 288) completed confidential surveys of demographic and health characteristics, stigma-avoidance non-adherence, and non-stigma-related predictors of non-adherence. Results found nearly half of participants (48%) had forgone taking their ART in social settings. Hierarchically structured regression models showed that alcohol use, medication concerns, and internalized HIV stigma significantly predicted ART non-adherence, accounting for 9.9% of the variance. Stigma-avoidance non-adherence explained an additional 2.6% of the variance in ART non-adherence. The current findings extend previous research to show that stigma-avoidance independently contributes to ART non-adherence, including over and above depression and alcohol use.

Ammon, N., Mason, S., & Corkery, J. M. (2018). Factors impacting antiretroviral therapy adherence among human immunodeficiency virus-positive adolescents in Sub-Saharan Africa: A systematic review. Public Health, 157, 20–31. https://doi.org/10.1016/j.puhe.2017.12.010CrossRefPubMed

Avert, H. (2018). South Africa: Progress towards the 90–90–90 Targets. Retrieved from https://www.avert.org/infographics/south-africa-progress-towards-90-90-90-targets-2017

Blake Helms, C., Turan, J. M., Atkins, G., Kempf, M. C., Clay, O. J., & Raper, J. L., et al. (2017). Interpersonal mechanisms contributing to the association between HIV-related internalized stigma and medication adherence. AIDS and Behavior, 21, 238–247. https://doi.org/10.1007/s10461-016-1320-2CrossRefPubMed

Camlin, C. S., Charlebois, E. D., Getahun, M., Akatukwasa, C., Atwine, F., Itiakorit, H., et al. (2020). Pathways for reduction of HIV‐related stigma: a model derived from longitudinal qualitative research in Kenya and Uganda. Journal of the International AIDS Society, 23, e25647–n/a. https://doi.org/https://doi.org/10.1002/jia2.25647

Centers for Disease, C., and Prevention. (2017). Compendium of evidence-based interventions and best practices for HIV prevention. Retrieved from https://www.cdc.gov/hiv/research/interventionresearch/compendium/

Cooper, V., Moyle, G. J., Fisher, M., Reilly, G., Ewan, J., & Liu, H. C., et al. (2011). Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz. AIDS Care, 23, 705–713. https://doi.org/10.1080/09540121.2010.534433CrossRefPubMed

Croome, N., Ahluwalia, M., Hughes, L. D., & Abas, M. (2017). Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa. AIDS, 31, 995–1007. https://doi.org/10.1097/QAD.0000000000001416CrossRefPubMed

de Bruin, M., Viechtbauer, W., Schaalma, H. P., Kok, G., Abraham, C., & Hospers, H. J. (2010). Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials. Archives of Internal Medicine, 170, 240–250. doi:https://doi.org/10.1001/archinternmed.2009.536

Earnshaw, V. A., & Chaudoir, S. R. (2009). From conceptualizing to measuring HIV stigma: A review of HIV stigma mechanism measures. AIDS and Behavior. https://doi.org/10.1007/s10461-009-9593-3CrossRefPubMedPubMedCentral

Earnshaw, V. A., Smith, L. R., Chaudoir, S. R., Amico, K. R., & Copenhaver, M. M. (2013). HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. AIDS and Behavior, 17, 1785–1795. https://doi.org/10.1007/s10461-013-0437-9CrossRefPubMedPubMedCentral

Heestermans, T., Browne, J. L., Aitken, S. C., Vervoort, S. C., & Klipstein-Grobusch, K. (2016). Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-Saharan Africa: A systematic review. BMJ Global Health, 1, e000125. https://doi.org/10.1136/bmjgh-2016-000125CrossRefPubMedPubMedCentral

Hoffman, S., Tymejczyk, O., Kulkarni, S., Lahuerta, M., Gadisa, T., & Remien, R. H., et al. (2017). Brief report: Stigma and HIV care continuum outcomes among Ethiopian adults initiating ART. Journal of Acquired Immune Deficiency Syndromes, 76, 382–387. https://doi.org/10.1097/QAI.0000000000001530CrossRefPubMed

Horne, R., Chapman, S. C., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013). Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS ONE, 8, e80633. https://doi.org/10.1371/journal.pone.0080633CrossRefPubMedPubMedCentral

Kalichman, S. C., Cain, D., Cherry, C., Kalichman, M., & Pope, H. (2005). Pillboxes and antiretroviral adherence: Prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care and STDs, 19, 49–55.CrossRef

Kalichman, S. C., Mathews, C., Banas, E., & Kalichman, M. O. (2019a). Stigma management intervention to improve antiretroviral therapy adherence: Phase-I test of concept trial, Cape Town South Africa. Global Public Health, 14, 1059–1074. https://doi.org/10.1080/17441692.2018.1552307CrossRefPubMed

Kalichman, S. C., Mathews, C., Banas, E., & Kalichman, M. O. (2019b). Treatment adherence in HIV stigmatized environments in South Africa: Stigma avoidance and medication management. International Journal of STD and AIDS, 30, 362–370. https://doi.org/10.1177/0956462418813047CrossRefPubMed

Kamaradova, D., Latalova, K., Prasko, J., Kubinek, R., Vrbova, K., & Mainerova, B. (2016). Connection between self-stigma, adherence to treatment, and discontinuation of medication. Patient Prefer Adherence, 10, 1289–1298. https://doi.org/10.2147/PPA.S99136CrossRefPubMedPubMedCentral

Keyes, K. M., Hatzenbuehler, M. L., McLaughlin, K. A., Link, B., Olfson, M., & Grant, B. F., et al. (2010). Stigma and treatment for alcohol disorders in the United States. American Journal of Epidemiology, 172, 1364–1372. https://doi.org/10.1093/aje/kwq304CrossRefPubMedPubMedCentral

Lacroix, E., Alberga, A., Russell-Mathew, S., McLaren, L., & von Ranson, K. (2017). Weight Bias: A systematic review of characteristics and psychometric properties of self-report questionnaires. Obesity Facts, 10, 223–237. https://doi.org/10.1159/000475716CrossRefPubMedPubMedCentral

Maisto, S. A., Conigliaro, J., McNeil, M., Kraemer, K., & Kelley, M. E. (2000). An empirical investigation of the factor structure of the AUDIT. Psychological Assessment, 12, 346–353.CrossRef

Pearson, C. R., Simoni, J. M., Hoff, P., Kurth, A. E., & Martin, D. P. (2007). Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues. AIDS and Behavior, 11, 161–173. https://doi.org/10.1007/s10461-006-9133-3CrossRefPubMedPubMedCentral

Petersen, M. L., Wang, Y., van der Laan, M. J., Guzman, D., & Riley, E., et al. (2007). Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: A marginal structural model analysis. Clinical Infectious Diseases, 45, 908–915.CrossRef

Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psych Measurement, 1, 385–401.CrossRef

Ramlagan, S., Peltzer, K., Ruiter, R. A. C., Barylski, N. A., Weiss, S. M., & Sifunda, S. (2018). Prevalence and factors associated with fixed-dose combination antiretroviral drugs adherence among HIV-positive pregnant women on Option B treatment in Mpumalanga Province, South Africa. Int J Environ Res Public Health, 15. doi:https://doi.org/10.3390/ijerph15010161

Simoni, J. M., Pearson, C. R., Pantalone, D. W., Marks, G., & Crepaz, N. (2006). Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load: A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr, 43, S23–S35. doi:https://doi.org/10.1097/01.qai.0000248342.05438.52

Sweeney, S. M., & Vanable, P. A. (2016). The Association of HIV-related stigma to HIV medication adherence: A systematic review and synthesis of the literature. AIDS and Behavior, 20, 29–50. https://doi.org/10.1007/s10461-015-1164-1CrossRefPubMed

Wang, X. Q., Petrini, M., & Morisky, D. E. (2016). Comparison of the quality of life, perceived stigma and medication adherence of Chinese with schizophrenia: A follow-up study. Archives of Psychiatric Nursing, 30, 41–46. https://doi.org/10.1016/j.apnu.2015.10.006CrossRefPubMed

Wilson, I. B., Fowler, F. J., Jr., Cosenza, C. A., Michaud, J., Bentkover, J., & Rana, A., et al. (2014). Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS and Behavior, 18, 2349–2358. https://doi.org/10.1007/s10461-013-0610-1CrossRefPubMed

Wilson, I. B., Tie, Y., Padilla, M., Rogers, W., & Beer, L. (2020). Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States. AIDS, 34, 2239–2247.CrossRef

Woodford, M. R., Howell, M. L., Kulick, A., & Silverschanz, P. (2013). “That’s so gay”: Heterosexual male undergraduates and the perpetuation of sexual orientation microagressions on campus. Journal of Interpersonal Violence, 28, 416–435. https://doi.org/10.1177/0886260512454719CrossRefPubMed

Titel: Forgoing antiretroviral therapy to evade stigma among people living with HIV, Cape Town, South Africa
verfasst von: Seth Kalichman
Catherine Mathews
Renee El-Krab
Ellen Banas
Moira Kalichman
Publikationsdatum: 31.03.2021
Verlag: Springer US
Erschienen in: Journal of Behavioral Medicine / Ausgabe 5/2021
Print ISSN: 0160-7715
Elektronische ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-021-00212-2

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Forgoing antiretroviral therapy to evade stigma among people living with HIV, Cape Town, South Africa

Abstract

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Typ-2-Diabetes und Depression folgen oft aufeinander

Darf man die Behandlung eines Neonazis ablehnen?

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

Update Psychiatrie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2021

Charity-based incentives motivate young adult cancer survivors to increase physical activity: a pilot randomized clinical trial

Past-year discrimination and cigarette smoking among sexual minority women: investigating racial/ethnic and sexual identity differences

Mindfulness-based stress reduction for breast cancer survivors (MBSR(BC)): evaluating mediators of psychological and physical outcomes in a large randomized controlled trial

Gender differences in the relationship between social support and strain and mortality among a national sample of adults

The bidirectional relationship between sense of purpose in life and physical activity: a longitudinal study

Web-based cognitive behavior therapy for chronic pain patients with aberrant drug-related behavior: How did it work and for whom?

Neu im Fachgebiet Psychiatrie

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Typ-2-Diabetes und Depression folgen oft aufeinander

Darf man die Behandlung eines Neonazis ablehnen?

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

Update Psychiatrie